综述 |
|
|
|
|
体外合成朊病毒的研究进展 |
刘东, 卢士英, 周玉, 宫彬彬, 任洪林, 柳增善 |
人兽共患病研究教育部重点实验室 吉林大学人兽共患病研究所 畜牧兽医学院 长春 130062 |
|
Progress on Prion Synthesis in vitro |
LIU Dong, LU Shi-ying, ZHOU Yu, GONG Bin-bin, REN Hong-lin, LIU Zeng-shan |
Key Laboratory for Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China |
引用本文:
刘东, 卢士英, 周玉, 宫彬彬, 任洪林, 柳增善. 体外合成朊病毒的研究进展[J]. 中国生物工程杂志, 2010, 30(10): 74-78.
LIU Dong, LU Shi-ying, ZHOU Yu, GONG Bin-bin, REN Hong-lin, LIU Zeng-shan. Progress on Prion Synthesis in vitro. China Biotechnology, 2010, 30(10): 74-78.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2010/V30/I10/74
|
[1] 赵德明.动物传染性海绵状脑病.北京:中国农业大学出版社,2005.58-59. Zhao D M. Animal Transmissible Spongiform Encephalopathies.Beijing: China Agricultural University Press, 2005.58-59.
[2] Raeber A J, Borchelt D R, Scott M, et al. Attemptes to convert the cellular prion protein into the scrapie isoform in cell-free systems. J Virol, 1992,66(10):6155-6163.
[3] Kocisko D A, Come J H, Priola S A, et al. Cell-free formation of protease-resistant prion protein. Nature,1994,370(6489):471-474.
[4] Maxson L, Wong C, Herrmann L M, et al. A solid-phase assay for identification of modulators of prion protein interactions. Anal Biochem, 2003,323(1):54-64.
[5] Kocisko D A, Baron G S, Rubenstein R, et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol, 2003,77(19):10288-10294.
[6] Silverira J R, Raymond G J, Hughson A G, et al. The most infectious prion protein particles. Nature, 2005,437(7056):257-267.
[7] Kirby L, Birkett C R, Rudyk H, et al. In vitro cell-free conversion of bacterial recombinant Pr Pto PrPres as a model for conversion. J Gen Virol, 2000,81(Pt4):2565-2571.
[8] Saborio G P, Soto C, Kascsak R J, et al. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem Biophys Res Commun, 1999,258(2):470-475.
[9] Saborio G P, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature, 2001,411(6839):810-813.
[10] Castilla J, Saá P, Morales R, et al. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol, 2006,412:3-21.
[11] Castilla J, Saá P, Hetz C, et al. In vitro generation of infectious scrapie prions. Cell, 2005,121(2):195-206.
[12] Soto C, Anderes L, Suardi S, et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett, 2005,579(3):638-642.
[13] Lucassen R, Nishina K, Suattapone S. In vitro amplification of protease-resistant prion protein requires free sulfhydryI groups. Biochemistry, 2003,42(14):4127-4135.
[14] Deleault N, Geoghegan J C, Nishina K, et al. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem, 2005,280(29):26873-26879.
[15] Deleault N R, Harris B T, Rees J R, et al. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA, 2007,104(23):9741-9746.
[16] Geoghegan J C, Valdes PA, Orem N R, et al. Selective incorporation of polyanionic molecules into hamster prions. J Biol Chem, 2007,282(50):34341-36353.
[17] Atarashi R, Moore R A, Sim V L, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.Nat Methods, 2007,4(8):645-650.
[18] Atarashi R, Wilham J M, Christensen L, et al. Simplified ultrasensitive prion detection by recombinant Pr Pconversion with shaking. Nat Methods, 2008,5(3):211-212.
[19] Wang F, Wang X, Yuan C G, et al. Generating a prion with bacterially expressed recombinant prion protein. Science, 2010,327(5969):1132-1135.
[20] Baskakov I V, Legname G, Baldwin M A, et al. Pathway complexity of prion protein assembly into amyloid. J Biol Chem. 2002,277(24):21140-21148.
[21] Bocharova O V, Breydo L, Parfenov A S, et al. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrPsc. J Mol Biol, 2005,346(2):645-659.
[22] Baskakov I V. Autocatalytic conversion of recombinant prion proteins displays a species barrier. J Biol Chem. 2004,279(9):7671-7677.
[23] Breydo L, Bocharova O V, Baskakov I V. Semiautomated cell-free conversion of prion protein: Applications for high-throughput screening of potential antiprion drugs. Anal Biochem, 2005,339(1):165-173.
[24] Legname G, Baskakov I V, Nguyen H O, et al. Sythetic mammalian prions. Science, 2004,305(5684):673-676.
[25] Westaway D, DeArmond S J, Cayetano-Canlas J, et al. Degeneration of skeletal muscle,peripheral nerves,and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell, 1994,76(1):117-129.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|